ASKFIRST
Live / Registered — Registered (as of 16 Dec 2025)
What this means for you
Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Dec 2031: the §8 declaration of use).
Record
- Serial number
- 98201386
- Registration number
- 8064544
- Mark type
- Word mark
- Filed
- 28 Sept 2023
- Published for opposition
- 28 Jan 2025
- Registered
- 16 Dec 2025
- Next maintenance filing
- §8 declaration of use, due by 16 Dec 2031 (grace period to 16 Jun 2032)
- Attorney of record
- Kristen Mollnow Walsh
Goods and services
- Class 035 — Advertising and business services: Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials
- Class 045 — Legal and security services: Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families
Owner
- ASKBIO INC., DURHAM, NC, US
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
- Asklepios BioPharmaceutical, Inc., Research Triangle Park, NC, US
Prosecution history
- 28 Jul 2026 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 07 Jul 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
- 17 Jun 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 19 Apr 2026 — POST REGISTRATION ACTION MAILED - SEC. 7
- 15 Apr 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jan 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 01 Oct 2025 — NOTICE OF ALLOWANCE CANCELLED
- 21 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Oct 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 14 Apr 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT